Embecta Acquires Owen Mumford Holdings for Up to £150 Million

March 27, 2026

Embecta entered into a definitive agreement to acquire Owen Mumford Holdings Limited for up to £150 million, consisting of £100 million upfront cash and up to £50 million in performance-based payments tied to net sales of the Aidaptus next-generation auto-injector platform. The deal was designed to accelerate embecta’s transformation into a broader medical supplies company with a differentiated drug-delivery platform for pharmaceutical partners and chronic care patients across obesity, diabetes, autoimmune diseases, and anaphylaxis.

Buyers
Embecta
Targets
Owen Mumford Holdings Limited
Location
Oxfordshire, United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.